Dendreon Corp. could gain more than $110 million in a deal with Genentech Inc. to develop monoclonal antibodies, small molecules and other products from Dendreon's preclinical Trp-p8 gene platform. (BioWorld Today)

Dendreon Corp. could gain more than $110 million in a deal with Genentech Inc. to develop monoclonal antibodies, small molecules and other products from Dendreon's preclinical Trp-p8 gene platform. (BioWorld Today)

WASHINGTON - If the U.S. Patent and Trademark Office wins approval of its proposed fee structure increase, biotechnology companies filing applications for patents could see their costs skyrocket. (BioWorld Today)

WASHINGTON - If the U.S. Patent and Trademark Office wins approval of its proposed fee structure increase, biotechnology companies filing applications for patents could see their costs skyrocket. (BioWorld Today)